Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 747 across all filing types
Latest filing 2020-12-10 Major Shareholding Noti…
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a detailed report submitted to stock exchanges regarding an inter-se transfer of shares among promoters and promoter group members of SMS Pharmaceuticals Limited. It references specific regulations under the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, particularly Regulation 10(6), which mandates reporting of acquisitions made under certain exemptions. The content includes names of acquirers, dates of acquisition, number of shares transferred, and compliance with disclosure timelines. This type of document is a formal notification of changes in significant share ownership levels, specifically related to promoter share transfers and acquisitions. It is not a financial report, earnings release, or management discussion, but a regulatory disclosure about shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and detail support a high confidence in this classification.
2020-12-10 English
Updates
Regulatory Filings
2020-12-08 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-12-01 English
Related Party Transactions
Regulatory Filings
2020-11-30 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a detailed disclosure regarding an inter-se transfer of shares between promoters/promoter group of SMS Pharmaceuticals Limited. It references compliance with Regulation 10(5) of SEBI (SAST) Regulations, 2011, which pertains to substantial acquisition of shares and takeovers. The document includes specifics about the number of shares transferred, names of acquirers and sellers, and the percentage of shareholding involved. It is a regulatory disclosure about share transactions within the promoter group, not a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data but is a formal notification to stock exchanges about share transfers. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or share transfers among promoters.
2020-11-27 English
Updates
Regulatory Filings
2020-11-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.